Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Violi

Showing results (31-40 of 234) with videos related to

Pageof 24
Sort By:
Haematologica|March 1, 1995
Antiphospholipid antibodies, hypercoagulability and thrombosisF Violi, D Ferro, C Quintarelli
Lancet (London, England)|September 18, 2001
Vitamin E supplementationF Violi, F Micheletta, L Iuliano
Journal of Thrombosis and Haemostasis : JTH|June 24, 2014
Pneumonia, thrombosis and vascular diseaseF Violi, R Cangemi, C Calvieri
Circulation|February 28, 2002
Synergism among flavonoids in inhibiting platelet aggregation and H2O2 productionF Violi, P Pignatelli, F M Pulcinelli
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
AspirinF Violi, P Pignatelli, F M Pulcinelli
Recenti Progressi in Medicina|March 1, 1986
[Clinical experience with a new uricolytic agent]C Alessandri, F Violi, M S Bonavita
Seminars in Nephrology|April 26, 2001
Hemodialitic treatment of cardiac failureL Iorio, L S De Santo, F Violi
Atherosclerosis|February 1, 1996
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. studyF Violi, M Criqui, A Longoni, et al.
Giornale Italiano Di Cardiologia|December 1, 1992
[Prostaglandins and ischemic cardiopathy]F Balsano, G Davì, F Violi, et al.
Current Drug Targets|October 28, 2003
Antioxidants in peripheral arterial diseaseF Violi, L Loffredo, A Mancini, et al.
Pageof 24

Showing results (31-40 of 234) with videos related to

Sort By:
Pageof 24
Haematologica|March 1, 1995
Antiphospholipid antibodies, hypercoagulability and thrombosisF Violi, D Ferro, C Quintarelli
Lancet (London, England)|September 18, 2001
Vitamin E supplementationF Violi, F Micheletta, L Iuliano
Journal of Thrombosis and Haemostasis : JTH|June 24, 2014
Pneumonia, thrombosis and vascular diseaseF Violi, R Cangemi, C Calvieri
Circulation|February 28, 2002
Synergism among flavonoids in inhibiting platelet aggregation and H2O2 productionF Violi, P Pignatelli, F M Pulcinelli
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
AspirinF Violi, P Pignatelli, F M Pulcinelli
Recenti Progressi in Medicina|March 1, 1986
[Clinical experience with a new uricolytic agent]C Alessandri, F Violi, M S Bonavita
Seminars in Nephrology|April 26, 2001
Hemodialitic treatment of cardiac failureL Iorio, L S De Santo, F Violi
Atherosclerosis|February 1, 1996
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. studyF Violi, M Criqui, A Longoni, et al.
Giornale Italiano Di Cardiologia|December 1, 1992
[Prostaglandins and ischemic cardiopathy]F Balsano, G Davì, F Violi, et al.
Current Drug Targets|October 28, 2003
Antioxidants in peripheral arterial diseaseF Violi, L Loffredo, A Mancini, et al.
Pageof 24